Today we are introducing the SCN2A research team at the Florey Institute. The team is lead by Prof Steven Petrou, Director of Florey Institute. The team has been developing a range of disease models, including computational, animal and human stem cell models to evaluate the impact of SCN2A variants and develop novel therapeutic strategies.
We will be sharing more about their work over the coming months.
Left to right: Dr. Svenja Pachernegg, Jacqueline Heighway, Linghan Jia, Lisa Drew, Dr. Snezana Maljevic, Claire Cuddy, Dr. Nikola Jancovski, Dr. Melody Li, Prof Steven Petrou, Dr. Geza Berecki
Anyone who wants to reach out to the research team to discuss involvement you can email them on: neurogen@florey.edu.au
